Forecast: R&D Capital Costs in Singapore

The R&D capital costs in Singapore are projected to decline steadily from 2024 to 2028. In 2024, the forecasted value stands at $813.91 million, decreasing by approximately 3.21% to $787.78 million in 2025. This downward trend continues with values of $762.17 million in 2026 (a 3.25% drop), $737.08 million in 2027 (a 3.29% decrease), and $712.49 million in 2028 (a 3.33% decline). Comparing to the actual 2023 figures, which were higher, this shows a clear trend of reducing investment in R&D capital costs over the forecast period. The Compound Annual Growth Rate (CAGR) over the five-year period indicates an average annual reduction of around 3.27%.

Future trends to watch for include potential increases in government support or private investment in R&D, the impact of emerging technologies on cost efficiencies, and changes in global economic conditions that may influence R&D spending in Singapore.

Top Countries about Biotechnology